XVI. International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors

Pharmacological Reviews

Volumn 50, Issue 1, 1998, Pages 143-150

  Michel, Martin C ^a,j   Beck Sickinger, Annette ^b   Cox, Helen ^c   Doods, Henri N ^d   Herzog, Herbert ^e   Larhammar, Dan ^f   Quirion, Remi ^g   Schwartz, Thue ^h   Westfall, Thomas ⁱ  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b ETH ZURICH   (Switzerland)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^e ST VINCENT S HOSPITAL   (Australia)

^f UPPSALA UNIVERSITY   (Sweden)

^g MCGILL UNIVERSITY   (Canada)

^h Rigshaspitalet   (Denmark)

ⁱ SAINT LOUIS UNIVERSITY   (United States)

^j UNIVERSITY HOSPITAL ESSEN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GR 231118; N [1 [4 [[[[4 [(DIMETHYLAMINO)METHYL]CYCLOHEXYL]METHYL]AMINO]IMINOMETHYL]BENZYL] 2 OXO 2 (1 PYRROLIDINYL)ETHYL] ALPHA [(2 NAPHTHALENYLSULFONYL)AMINO]BENZENEPROPANAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y3 RECEPTOR; PANCREAS POLYPEPTIDE; PEPTIDE YY; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; HORMONE RECEPTOR INTERACTION; HUMAN; INTERNATIONAL COOPERATION; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, NEUROPEPTIDE Y; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TERMINOLOGY;

EID: 0031919929     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Ball HJ, Shine J and Herzog H (1995) Multiple promoters regulate tissues-specific expression of the human NPY-Y1 receptor gene. J Biol Chem 270:27272-27276.
2. Bard JA, Walker MW, Branchek TA and Weinshank RL (1995) Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J Biol Chem 270:26762-26765.
3. 18-36) and peptide YY (PYY) on rat adrenal capsule/zona glomerulosa. Regul Pept 52:187-193.
4. 5 are involved in the renal effects of neuropeptide Y. Br J Pharmacol 120:1335-1343.
5. Bloroovist AG, Roubos EW, Larhammar D and Martens GJM (1995) Cloning and sequence analysis of a neuropeptide Y/peptide Y recepor Yl cDNA from Xenopus laevis. Biochim Biophys Acta 1261:439-441.
6. Colmers WF and Bleakman D (1994) Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci. 17:373-379.
7. Colmers WF and Pittman QJ (1989) Presynaptic inhibition by neuropeptide Y and baclofen in hippocampus: Insensitivity to pertussis toxin treatment. Brain Res 498:99-104
8. Daniels AJ, Matthews JE, Slepetis RJ, Jansen M. Viveros OH, Tadepalli A, Harrington W, Heyer D, Landavazo A, Leban JJ and Spaltenstein A (1995) High-affinity neuropeptide Y receptor antagonists. Proc Natl Acad Sci USA 92:9067-9071.
9. Doods HN, Wieland HA, Engel W, Eberlein W, Willim K-D, Entzeroth M, Wienen W and Rudolf K (1996) BIBP 3226, the first selective NPY Yl receptor antagonist: A review of its pharmacological properties. Regul Pept 65:71-77.
10. 3 receptor sub-type. Mol Brain Res 26:320-324
11. Eberlein GA, Eysselein VE, Schaeffer M, Layer P, Grandt D, Goebell H, Niebel W, Davis M, Lee TD, Shivel JE and Reeve JRJ (1989) A new molecular form of PYY: Structural characterization of human PYY(3-36) and PYY(l-36). Peptides 10: 797-803.
12. Eva C. Keinänen K, Monyer H, Seeburg P and Sprengel R (1990) Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Lett 271:81-84.
13. Eva C, Oberto A, Sprengel R and Genazzani E (1992) The murine NPY-1 receptor gene. Structure and delineation of tissue-specific expression. FEBS Lett 314:285-288.
14. 2+ channels in sensory neurons. Proc Natl Acad Sci USA 85:3633-3637.
15. Feth F, Rascher W and Michel MC (1992) Neuropeptide Y (NPY) receptors in HEL cells: Comparison of binding and functional parameters for full and partial agonits and a nonpeptide antagonist. Br J Pharmacol 105:71-76.
16. Foucart S and Majewski H (1989) Inhibition of noradrenaline release by neuropeptide Y in mouse atria does not involve inhibition of adenylate cyclase or a pertuasis toxinsusceptible G protein. Naunyn-Schmiedeberg's Arch Pharmacol 340:658-665.
17. 1 receptor agonist. Proc Natl Acad Sci USA 87:182-186.
18. Gehlert DR, Beavers LS, Johnson D, Gackenheimer SL, Schober DA and Gadski RA (1996b) Expression cloning of a human brain neuropeptide Y Y2 receptor. Mol Pharmacol 49:224-228.
19. Gehlert DR, Schober DA, Beavers L, Gadski R, Hoffinan JA, Smiley DL. Chance RE, Lundell I and Larhammar D (1996a) Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor Mol Pharmacol 56:112-118.
20. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaflhauser AO, Whitebread S, Hofbaur KG, Taber RI, Branchek TA and Weinshank RL (1996) A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382:168-171.
21. Gerald C, Walker MW, Vayne PJ-J, He C, Branehek TA and Weinshank RL (1995) Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J Biol Chem 270:26758-26761.
22. 1-selective agonist at peptide YY/neuropeptide Y receptors. Bur J Pharmacol 269: 127-132.
23. Grandt O, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE and Reeve JR Jr (1994b) Two molecular forma of peptide YY (PYY) are abundant in human blood. Characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 51:151-159.
24. Grandt D, Schimiczek M, Rascher W, Feth F, Shively J, Lee TD, Davis MT, Reeve JR Jr and Michel MC (1996) Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors. Regul Pept 67:33-37.
25. Grandt D, Teyssen S, Schimiczek M, Reeve JR Jr, Feth F, Rascher W, Hirche H, Singer MV, Layer P, Goebell H, Ho FJ and Eysselein VE (1992) Novel generation of hormone receptor specificity by amino terminal processing of peptide YY. Biochem Biophyt Res Commun 186:1299-1306.
26. Gregor P, Feng Y, Decarr LB, Cornfield LJ and McCaleb ML (1996b) Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue. J Biol Chem 271:27776-27781.
27. Gregor P, Millham ML, Feng Y, Decarr LB, McCaleb ML and Cornfield LJ (1996a) Cloning and characterization of a novel receptor to pancreatic polypeptide, a member of the neuropeptide Y receptor family. FEES Lett 381:58-62.
28. Grundemar L, Wahlestedt C and Reis DJ (1991) Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem. J Pharmacol Exp Ther 258:633-638.
29. 1 receptor antagonist. J Pharmacol Exp Ther 275:1261-1266.
30. Herzog H, Baumgartner M, Vivero C, Selbie LA, Auer B and Shine J (1993a) Genomic organization, localization, and allelic differences in the gene for the human neuropeptide Y Yl receptor. J Biol Chem 268:6703-6707.
31. Herzog H, Hort YJ, Shine J and Selbie LA (1993b) Molecular cloning, characterization, and localization of the human homolog to the reported bovine NPY Y3 receptor: Lack of NPY binding and activation. DNA Cell Biol 12:465-471.
32. Hexum TD, Zheng J and Zhu J (1994) Neuropeptide Y inhibition of nicotinic receptor-mediated chromaffin cell secretion. J Pharmacol Exp Ther 271:61-66.
33. Hirabayashi A, Nishiwaki K, Shimada Y and Ishikawa N (1996) Role of neuropeptide Y and its receptor subtypes in neurogenic pulmonary edema. Eur J Pharmacol 296:297-305.
34. Hu Y, Bloomquist BT, Cornfield LJ, Decarr LB, Flores-Riveros JR, Friedman L, Jiang P, Lewis-Higgins L, Sadlowski Y, Schaefer J, Velazquez N and McCaleb ML (1996) Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J Biol Chem 271:26315-26319.
35. Jazin EE, Yoo H, Blomqvist AG, Yee F, Weng G, Walker MW, Salon J, Larhammar D and Wahlestedt C (1993) A proposed bovine neuropeptide Y (NPY) receptor cDNA clone, or its human homologue, confers neither NPY binding sites nor NPY responsiveness on transfected cells. Regul Pept 47:247-253.
36. Krause J, Eva C, Seeburg PH and Sprengel R (1992) Neuropeptide Y, subtype pharmacology of a recombinantly expressed neuropeptide receptor. Mol Pharmacol 41:817-821.
37. Larhammar D (1996a) Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept 62:1-11.
38. Larhammar D (1996b) Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept 65:165-174.
39. Larhammar D, Blomqvist AG, Yee F, Jazin E, Yoo H and Wahlestedt C (1992) Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem 267:10935-10938.
40. 1 mRNA in forebrain areas of the rat central nervous system. Eur Neurosci 5:1622-1637.
41. + channels in a human neuroblastoma cell line. Pfluegers Arch Eur J Physiol 430:534-540.
42. Li X-J, Wu Y-N, North A and Forte M (1992) Cloning, functional expression and developmental regulation of a neuropeptide Y receptor from Drosophila melanogaster. J Biol Chem 267:9-12.
43. Limbird LE (1988) Receptors linked to inhibition of adenylate cyclase: Additional signaling mechanisms. FASEB J 2:2686-2695.
44. Lundberg JM (1996) Pharmacology of cotransmission in the autonomic nervous system: Integrative aspects on amines, neuropeptides, adenosine triphospnate, amino acids and nitric oxide. Pharmacol Rev 48:113-178.
45. Lundell I, Blomqvist AG, Berglund MM, Schober DA, Johnson D, Statnick MA, Gadski RA. Gehlert DR and Larhammar D (1995) Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem 270:29123-29128.
46. Lundell I, Statnick MA. Johnson D, Schober DA, Starback P, Gebiert DR and Larhammar D (1996) The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologous human receptor. Proc Natl Acad Sci USA 93:5111-5115.
47. Martin SE and Patterson RE (1989) Coronary constriction due to neuropeptide Y: Alleviation with cyclooxygenase blockers. Am J Physiol 257:H927-H934.
48. Matsumoto M, Nomura T, Momose K, Ikeda Y, Kondou Y, Akiho H, Togami J, Kimura Y, Okada M and Yamaguchi T (1996) [nactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J Biol Chem 271:27217-27220.
49. McCullough LA and Wertfall TC (1995) Neuropeptide Y inhibits dcpolarization-stimulated catecholamine synthesis in rat pheochromocytoma cells. Eur J Pharmacol 287:271-277.
50. Mentlein R, Dahims P, Grandi D and Krüger R (1993) Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul Pept 49:133-144.
51. Michel MC and Rascher W (1995) Neurapeptide Y - a possible role in hypertension? J Hypertens 13:385-395.
52. Michel MC, Schlicker E, Pink K, Boublik JH. Göthert M, Willette RN, Daly RN, Hieble JP, Rivier JE and Motulsky HJ (1990) Distinction of NPY receptors in vetro and in vivo. I. NPY-(18-36) discriminates NPY receptor subtypes in vitro. Am J Physiol 250:E131-E139.
53. Millar BC, Weis T, Piper HM, Weber M, Borchard U, McDermott BJ and Balasubramaniam A (1991) Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes. Am J Physiol 261:H1727-H1733.
54. ++ and Inhibits adenylate cyclase in human erythroleukemia cells. Am J Physiol 255:E880-E886.
55. Mousli M and Landry Y (1994) Role of positive charges of neuropeptide Y fragments in mast cell activation. Agents Actions 41:C41-C42.
56. Nakamura M, Sakanaka C, Aoki Y, Ogasawara H, Tsuji T, Kodama H, Matsumote T, Shimizu T and Noma M (1995) Identification of two isoforms of mouse neoropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomie structure, and function expression of the receptors. J Boil Chem 270:30102-30110.
57. 3-type neuropeptide Y receptors via the adenylate cyclaae/protein kinase A system. Naunyn-Schmiedeberg's Arch Pharmacol 351:337-347.
58. Perney TM and Miller RJ (1989) Two different G-proteins mediate neuropeptide Y and bradykinin-stimulated phospholipid breakdown in cultured rat sensory neurons. J Biol Chem 264:7317-7327.
59. 125I)NPY binding sites. J Neuroimmunol 54:81-86.
60. Playford RJ and Cox HM (1996) Peptide YY and neuropeptide Y: Two peptides intimately involved in electrolyte homeostasis. Trends Pharmacol Sci 17:436-438.
61. Rimland J, Xin W, Sweetnam P, Saijoh K, Nestler EJ and Duman RS (1991) Sequence and expression of a neuropeptide Y receptor cDNA. Mol Pharmacol 40:869-875.
62. 2 receptor for neuropeptide Y. Mol Pharmacol 49:387-390.
63. Roman FJ, Pascaud X, Duffy O, Vauche D, Martin B and Junien JL (1989) Neuropeptide Y and peptide YY interact with rat brain σ and PCP binding sites. Eur J Pharmacol 174:301-302.
64. Rose PM, Fernandes P, Lynch JS, Frazier ST, Fisher SM, Kodukula K, Kienzle B and Seethala R (1995) Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem 270:22661-22664.
65. Serradeil-Le Gal C, Valette G, Rouby P-E, Pellet A, Oury-Donat F, Brossard G, Lespy L, Marty E, Neliat G, de Cointet P, Maffrand J-P and Le Fur G (1995) SR120819A, an orally-active and selective neuropeptide Y Y1 receptor antagonist. FEBS Lett 362:192-196.
66. Sheikh SP (1991) Neuropeptide Y and peptide YY: Major modulators of gastrointestinal blood flow and function. Am J Physiol 261:G701-G715.
67. Sundler F, Böttcher G, Ekblad E and Hakanson R (1993) PP, PYY, and NPY: Occurrence and distribution in the periphery, in The Biology of Neuropeptide Y and Related Peptides (Colmers WF and Wahlestedt C, eds) pp 157-196, Humans Press, Totowa, NJ.
68. Tarn SW and Mitchell KN (1991) Neuropeptide Y and peptide YY do not bind to brain σ and phencyclidine binding sites. Eur J Pharmacol 193:121-122.
69. Wahlestedt C, Pich EM, Koob GF, Yee F and Heilig M (1993) Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 250:528-531.
70. Wahlestedt C, Yanaihara N and Hakanson R (1986) Evidence for different pre- and post-junctional receptors for neurupeptide Y and related peptides. Regul Pept 13:307-318.
71. Wang Z-L, Bennet WM, Wang R-M, Ghatei MA and Bloom SR (1994) Evidence of a paracrine role of neuropeptide-Y in the regulation of insulin release from pancreatic islets of normal and dexamethasone-treated rats. Endocrinology 135:200-206.
72. Weinberg DH, Sirinatsinghji DJS, Tan CP, Shiao L-L, Morin N, Rigby MR, Heavens RH, Rapoport DR, Bayne MI, Cascieri MA, Strader CD, Linemeyer DL add MacNeil DJ (1996) Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem 271:16485-16488.
73. Wettstein JG, Earley B and Junien JL (1995) Central nervous system pharmacology of neuropeptide Y. Pharmacol & Ther 65:397-414.
74. Wharton J, Gordon L, Byene J, Herzog H, Selbie LA, Moore K, Sullivan MHF, Elder MG, Moecoso G, Taylor KM, Shine J and Polak JM (1993) Expression of the human neuropeptide tyrosine Yl receptor Proc Natl Acad Sci USA 90:687-691.
75. Wieland HA. Willim K and Doods HN (1995a) Receptor binding profiles of NPY analogues and fragments in different tissues and cell lines. Peptides 16:1389-1394.
76. Wieland HA, Willim KD, Entzeroth M, Wienen W, Rudolf K, Eberlein W, Engel W and Doods HN (1995b) Subtype selectivity and antagonistic profile of the nonpeptide Yl receptor antagonist BIBP 3226. J Pharmacol Exp Ther 275:143-149.
77. + channels in vascular smooth muscle cells by neuropeptide Y. Pfluegers Arck J Physiol 431:110-116.
78. Yan H, Yang J, Marasco J, Yamaguchi K, Brenner S, Collins F and Karbon W (1996) Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors. Proc Natl Acad Sci USA 93:4661-4665.
79. Zhang X, Shi T, Hohnberg K, Landry M, Huang W, Xiao H, Ju G and Hökfelt T (1997) Expression and regulation of the neuropeptide Y Y2 receptor in sensory and autonomic ganglia. Proc Notl Acad Sci USA 94:729-734.